http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006093973-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74817a15dd20b0af2f742ca47b6e18e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb3dce169137d6783d465bcce8e6eb02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8268e39ce70ff2ad19742e2a21d5a90c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab24fe533b79524e510ea8e14feeb009 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-908 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 |
filingDate | 2006-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5df4828aee18dc2f96b0e9bb05c10fe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ee6bf38701eabf1506c9a66d6afd044 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c916e70b762fe6cc14e915afda183969 |
publicationDate | 2006-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2006093973-A2 |
titleOfInvention | Biomarkers of vulnerable a therosclerotic plaques and methods of use |
abstract | The present invention provides compositions suitable for use as biomarkers of vulnerable plaques as well as methods for the use of such compositions. In preferred embodiments, specific molecular imaging agents are provided that permit the selective identification of vulnerable plaques in coronary and other arteries using non- invasive imaging methods. Such specific molecular imaging agents comprise a binding partner linked to a detectable label that can be used in vivo to visualize vulnerable plaques. In certain preferred embodiments, the binding partner is a peptide that binds selectively to a component of a vulnerable plaque. In other preferred embodiments, the binding partner is an antibody that binds selectively to a component of a vulnerable plaque. In other preferred embodiments, the binding partner is a portion of a polypeptide displayed by a bacteriophage that binds selectively to a component of a vulnerable plaque. In preferred embodiments, the component of a vulnerable plaque is myeloperoxidase or a portion thereof. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9782501-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013072438-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013072714-A1 |
priorityDate | 2005-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 648.